Assenagon Asset Management’s Tarsus Pharmaceuticals TARS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $40.4M | Sell |
997,587
-127,718
| -11% | -$5.17M | 0.06% | 223 |
|
|
2025
Q1 | $57.8M | Sell |
1,125,305
-21,507
| -2% | -$1.1M | 0.1% | 172 |
|
|
2024
Q4 | $63.5M | Buy |
1,146,812
+5,565
| +0.5% | +$308K | 0.1% | 156 |
|
|
2024
Q3 | $37.5M | Buy |
1,141,247
+77,825
| +7% | +$2.56M | 0.07% | 198 |
|
|
2024
Q2 | $28.9M | Buy |
+1,063,422
| New | +$28.9M | 0.06% | 205 |
|
|
2023
Q3 | – | Sell |
-146,194
| Closed | -$2.64M | – | 1421 |
|
|
2023
Q2 | $2.64M | Hold |
146,194
| – | – | 0.01% | 650 |
|
|
2023
Q1 | $1.84M | Sell |
146,194
-37,014
| -20% | -$465K | 0.01% | 843 |
|
|
2022
Q4 | $2.69M | Sell |
183,208
-19,217
| -9% | -$282K | 0.01% | 683 |
|
|
2022
Q3 | $3.47M | Sell |
202,425
-159,316
| -44% | -$2.73M | 0.01% | 542 |
|
|
2022
Q2 | $5.28M | Buy |
+361,741
| New | +$5.28M | 0.02% | 504 |
|